Immunomedics Inc. | Ownership
Companies that own Immunomedics Inc.
venBio Select Advisor LLC
17,714,461
9.48%
775,000
16.17%
06/30/2018
The Vanguard Group, Inc.
13,896,834
7.44%
5,473,551
0.01%
06/30/2018
BlackRock Fund Advisors
10,446,171
5.59%
1,936,785
0.01%
06/30/2018
T. Rowe Price Associates, Inc.
8,769,819
4.69%
1,790,358
0.03%
06/30/2018
Fidelity Management & Research Co.
8,494,182
4.55%
699,658
0.02%
06/30/2018
SSgA Funds Management, Inc.
5,326,578
2.85%
-996,270
0.01%
06/30/2018
OrbiMed Advisors LLC
4,944,573
2.65%
-766,201
1.38%
06/30/2018
Palo Alto Investors LP
4,803,364
2.57%
7,356
4.95%
06/30/2018
Acuta Capital Partners LLC
4,750,000
2.54%
-1,100,000
22.18%
06/30/2018
ArrowMark Colorado Holdings LLC
4,312,171
2.31%
-636,214
1.03%
06/30/2018
| Address |
300 The American Road
Morris Plains New Jersey 07950
United States
|
|
Employees
|
- |
| Website |
http://www.immunomedics.com |
| Updated |
07/08/2019 |
| Immunomedics, Inc. is a clinical-stage biopharmaceutical company, which engages in the business of researching, developing, manufacturing and marketing biopharmaceutical products. It focuses on monoclonal antibody-based products for the targeted treatment of cancer. It operates through the United States, and Europe geographical segments. |
